Check to see if your fund on the Singapore shortlist, which is based on FE Analytics quantitative filters that test for alpha, volatility and consistency over multiple time periods.
Category: News
HK shortlist
The 15 category shortlist for Hong Kong is based on FE Analytics quantitative filters that test for alpha, volatility and consistency over multiple time periods.
Schroders RQFII license for Singapore business
Schroder Investment Management (Singapore) has received a Renminbi Qualified Foreign Institutional Investor license from the China Securities Regulatory Commission, which will enable it to tap the investment opportunities in China’s onshore markets.
HK regulators ban trader for life
The Securities and Futures Commission has put a lifetime ban on a derivatives trader who fled Hong Kong after being caught concealing risk and losses.
East Capital launches frontier markets fund
East Capital has launched a new frontier markets fund focused on “young and fast-growing” markets with an emerging middle class and strong consumption growth.
BlackRock what to watch out for
An optimistic consensus about US-driven growth in 2015 seems to have formed across the industry, prompting BlackRock’s strategy guru to cite key potential risks in that picture.
Cerulli on China smaller funds
The China Securities Regulatory Commission’s is cracking down on small “zombie funds”, but a rash of fund terminations remains unlikely, according to Cerulli Associates.
Threadneedle Columbia Management
Threadneedle Investments will, in the first half of the year, rebrand its business as Columbia Threadneedle Investments, a name that represents the combined capabilities of the firm and its US-based affiliate Columbia Management.
India and China appeal to top equity funds
India and China, two of the best performing Asian markets, have emerged as the favored country bets for most of the top performing Asia ex-Japan performing funds in 2014.
Hearing date set for Moodys Red Flag report
A September court date has been set to review Hong Kong’s disciplinary decision against the ratings agency for publishing a report that warned about risks at listed Chinese companies.
